What are the possible causes and recommended workup for a patient with a normal FEV1/FVC ratio, normal FEV1 and FVC, but a reduced diffusing capacity of the lungs for carbon monoxide (DLCO)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 6, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Normal Spirometry with Isolated Reduced DLCO

When a patient presents with normal FEV1/FVC ratio, normal FEV1 and FVC, but reduced DLCO, this pattern indicates impaired gas exchange without ventilatory defect and requires systematic evaluation for pulmonary vascular disease, early interstitial lung disease, emphysema, or extrapulmonary causes.

Interpretation of This Pattern

This specific pulmonary function test pattern is clinically significant and surprisingly common. The guideline framework emphasizes that additional studies beyond spirometry are essential when clinical suspicion exists, as spirometry alone misses important pathology 1.

Key Physiological Considerations

  • DLCO measures gas exchange efficiency across the alveolar-capillary membrane
  • Normal spirometry indicates preserved airflow and lung volumes
  • The dissociation between normal mechanics and impaired diffusion points to:
    • Alveolar-capillary membrane abnormalities
    • Reduced pulmonary capillary blood volume
    • Ventilation-perfusion mismatch
    • Early parenchymal disease

Differential Diagnosis (Prioritized by Clinical Impact)

1. Pulmonary Vascular Disease (Highest Mortality Risk)

  • Pulmonary arterial hypertension
  • Chronic thromboembolic disease
  • Pulmonary vasculitis
  • Clinical clue: Exertional dyspnea disproportionate to spirometry 2
  • Recent evidence shows reduced pulmonary vascular volume correlates with low DLCO independent of emphysema extent 3

2. Early Interstitial Lung Disease

  • Mild ILD may present before spirometric restriction develops 4
  • Next step: High-resolution CT chest to evaluate for interstitial lung abnormalities
  • A low DLCO with normal spirometry significantly increases pre-test probability of ILD 2

3. Emphysema (Especially in Smokers)

  • Can occur with preserved FEV1/FVC in early disease 5
  • Emphysema is independently associated with isolated reduced DLCO (OR 2.6) 5
  • Smoking history is critical: Each 10 pack-years increases odds of reduced DLCO by 1.6-fold 5
  • CT quantification shows emphysema correlates with DLCO reduction 3

4. Anemia

  • Reduced hemoglobin decreases CO uptake
  • Correct DLCO for hemoglobin before interpreting as truly abnormal
  • Simple, reversible cause that must be excluded first

5. Cardiovascular Disease

  • Left ventricular dysfunction
  • Exertional chest pain independently associates with isolated reduced DLCO (OR 1.6) 5

6. Extrapulmonary Causes

  • Obesity (paradoxically protective in population studies 5)
  • Chest wall abnormalities
  • Neuromuscular disease affecting respiratory muscles

Recommended Diagnostic Workup Algorithm

Step 1: Verify and Correct the DLCO

  • Confirm proper test technique (adequate breath-hold, no leak)
  • Correct for hemoglobin level - obtain CBC if not recent
  • Correct for altitude if applicable
  • Consider carboxyhemoglobin if smoker tested recently after smoking

Step 2: Measure Total Lung Capacity (TLC)

  • Essential to rule out early restriction 1
  • Body plethysmography preferred over gas dilution
  • Caveat: VA from single-breath DLCO test systematically underestimates TLC and should not be used to diagnose restriction 1

Step 3: Assess KCO (Transfer Coefficient)

  • KCO = DLCO/VA provides additional diagnostic information 6
  • Low DLCO with low KCO: Suggests true alveolar-capillary pathology
  • Low DLCO with normal/high KCO: May indicate reduced lung volume or uneven ventilation distribution
  • Both indices are vital for precise interpretation 6

Step 4: Clinical Context and Targeted Testing

If smoker or emphysema suspected:

  • High-resolution CT chest with quantitative emphysema assessment
  • Consider alpha-1 antitrypsin level if early-onset or family history

If ILD suspected (dyspnea, crackles, connective tissue disease):

  • High-resolution CT chest
  • Serologic workup (ANA, RF, anti-CCP, myositis panel)
  • Consider rheumatology referral

If pulmonary vascular disease suspected (exertional dyspnea, chest pain):

  • Echocardiogram with estimated pulmonary artery pressure
  • BNP/NT-proBNP
  • Ventilation-perfusion scan or CT pulmonary angiography
  • Exercise testing may reveal elevated VE/VCO2 slope 3
  • Consider right heart catheterization if suspicion high

If cardiac disease suspected:

  • Echocardiogram
  • BNP
  • Cardiology evaluation

Step 5: Consider Exercise Testing

  • Cardiopulmonary exercise testing can reveal:
    • Gas exchange abnormalities during stress
    • Elevated VE/VCO2 (ventilatory inefficiency)
    • Oxygen desaturation
    • Cardiovascular limitation
  • Particularly useful when resting studies are equivocal 3

Clinical Significance and Prognosis

DLCO below 40% predicted or decline >4 units annually is associated with increased morbidity and mortality 2. This makes serial monitoring essential once reduced DLCO is identified.

In a large population study, 37.8% of patients with normal spirometry had abnormally low DLCO 7, emphasizing that spirometry alone misses substantial pathology. The recommendation is clear: perform DLCO alongside spirometry in all healthcare settings to ensure timely diagnosis 7.

Common Pitfalls to Avoid

  1. Assuming normal spirometry means normal lungs - This is false; isolated reduced DLCO has significant clinical implications
  2. Using VA from DLCO test to diagnose restriction - This systematically underestimates TLC and leads to misclassification 1
  3. Ignoring hemoglobin correction - Anemia artifactually lowers DLCO
  4. Failing to obtain TLC - Cannot distinguish true isolated DLCO reduction from early restriction without measuring TLC
  5. Overlooking pulmonary vascular disease - This carries highest mortality risk and requires specific evaluation
  6. Not considering smoking history - Even without spirometric obstruction, smoking strongly associates with reduced DLCO 5

Symptoms Associated with Isolated Reduced DLCO

Population data reveals independent associations with 5:

  • Exertional chest pain (OR 1.6)
  • Breathing problems (OR 1.4)
  • Coughing (OR 1.2)
  • Self-reported lung disease other than asthma/COPD (OR 1.8)

These symptoms should heighten clinical concern and lower threshold for comprehensive workup.

Related Questions

What does a mildly reduced diffusing capacity of the lung for carbon monoxide (DLCO) indicate on pulmonary function testing (PFT)?
What is the appropriate evaluation and management of low diffusing capacity of the lung for carbon monoxide (DLCO) causing dyspnea on exertion?
How to determine if a Diffusing Capacity of the Lung for Carbon Monoxide (DLCO) report is acceptable in a patient with a known history of respiratory disease, such as Chronic Obstructive Pulmonary Disease (COPD) or interstitial lung disease?
Should the diffusing capacity of the lung for carbon monoxide (DLCO) be measured when the forced expiratory volume in one second (FEV1) is normal?
What is the significance and management of a reduced Diffusing Capacity of the Lung for Carbon Monoxide (DLCO)?
What oral therapies are recommended for managing atopic dermatitis, including dosing, monitoring, and alternative options?
Can chronic exposure to vapors, gases, dust, fumes, solvents, heavy metals, or gasoline cause chronic obstructive pulmonary disease (COPD), and what is the typical latency period before it presents?
In a female patient taking lurasidone who becomes restless when activities slow down, could her agitation be due to medication‑induced akathisia rather than just anxiety?
In a patient with chronic benzodiazepine use who presents with a Glasgow Coma Scale of 8, should flumazenil be administered?
How should I manage a patient with burning dry mouth who tested negative for Sjögren’s syndrome?
In a 53-year-old male ICU patient with heart failure (ejection fraction 27%), malignant left middle cerebral artery infarct, type 2 diabetes mellitus, pneumonia, acute kidney injury on chronic kidney disease requiring hemodialysis, status post tracheostomy, who has persistent hiccups despite metoclopramide (Plasil) 1 ampoule IV every 8 hours, what additional medications can be used to treat the hiccups?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.